Advanced search
Publication Cover
Pharmacogenomics Volume 10, 2009 - Issue 9
Submit an article Journal homepage
193
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Flavin-Containing Monooxygenase 3 Polymorphisms in 13 Ethnic Populations from Europe, East Asia and Sub-Saharan Africa: Frequency and Linkage Analysis

Mao Mao1 Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Ent 61, SE-751 85Uppsala, Sweden Tel.: +46 186 115 959; fax: +46 186 113 703; [email protected]View further author information
,
Alice Matimba2 IIDMM, University of Cape Town, South Africa;3 African Institute of Biomedical Science and Technology, Harare, ZimbabweView further author information
,
Maria G Scordo1 Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Ent 61, SE-751 85Uppsala, Sweden Tel.: +46 186 115 959; fax: +46 186 113 703; [email protected];4 University of Messina, Messina, ItalyView further author information
,
Arzu Gunes1 Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Ent 61, SE-751 85Uppsala, Sweden Tel.: +46 186 115 959; fax: +46 186 113 703; [email protected];5 Gazi University, Ankara, TurkeyView further author information
,
Hakan Zengil5 Gazi University, Ankara, TurkeyView further author information
,
Norio Yasui-Furukori6 Hirosaki University, Hirosaki, JapanView further author information
,
Collen Masimirembwa3 African Institute of Biomedical Science and Technology, Harare, ZimbabweView further author information
&
Marja-Liisa Dahl1 Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Ent 61, SE-751 85Uppsala, Sweden Tel.: +46 186 115 959; fax: +46 186 113 703; [email protected]View further author information
 show all
Pages 1447-1455 | Published online: 17 Sep 2009

Bibliography

  • Krueger SK , WilliamsDE: Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.Pharmacol. Ther.106(3) , 357–387 (2005).
  • Cashman JR , ZhangJ: Human flavin-containing monooxygenases.Annu. Rev. Pharmacol. Toxicol.46 , 65–100 (2006).
  • Cashman JR : Structural and catalytic properties of the mammalian flavin-containing monooxygenase.Chem. Res. Toxicol.8(2) , 166–181 (1995).
  • Lomri N , GuQ, CashmanJR: Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver.Proc. Natl. Acad. Sci. USA92(21) , 9910 (1995).
  • Overby LH , CarverGC, PhilpotRM: Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans.Chem. Biol. Interact.106(1) , 29–45 (1997).
  • Cashman JR , ParkSB, YangZC et al.: Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.Drug Metab. Dispos.21(4) , 587–597 (1993).
  • Park SB , JacobP 3rd, Benowitz NL, Cashman JR: Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1´-oxide. Chem. Res. Toxicol.6(6) , 880–888 (1993).
  • Motika MS , ZhangJ, CashmanJR: Flavin-containing monooxygenase 3 and human disease.Expert Opin. Drug Metab. Toxicol.3(6) , 831–845 (2007).
  • Park CS , KangJH, ChungWG et al.: Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: Linkage and effects on in vivo and in vitro FMO activities.Pharmacogenetics12(1) , 77–80 (2002).
  • Cashman JR , ZhangJ, LeushnerJ, BraunA: Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.Drug Metab. Dispos.29(12) , 1629–1637 (2001).
  • Hao DC , SunJ, FurnesB et al.: Haplotype frequency distribution and linkage disequilibrium analysis of single nucleotide polymorphisms at the human FMO3 gene locus.Biochem. Genet.44(7–8) , 388–407 (2006).
  • Lattard V , ZhangJ, TranQ, FurnesB, SchlenkD, CashmanJR: Two new polymorphisms of the FMO3 gene in Caucasian and African–American populations: Comparative genetic and functional studies.Drug Metab. Dispos.31(7) , 854–860 (2003).
  • Cashman JR , AkermanBR, ForrestSM, TreacyEP: Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.Drug Metab. Dispos.28(2) , 169–173 (2000).
  • Brunelle A , BiYA, LinJ et al.: Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions.Drug Metab. Dispos.25(8) , 1001–1007 (1997).
  • Stormer E , RootsI, BrockmollerJ: Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.Br. J. Clin. Pharmacol.50(6) , 553–561 (2000).
  • Shimizu M , YanoH, NagashimaS et al.: Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.Drug Metab. Dispos.35(3) , 328–330 (2007).
  • Lambert DM , MamerOA, AkermanBR et al.: In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.Mol. Genet. Metab.73(3) , 224–229 (2001).
  • Kang JH , ChungWG, LeeKH et al.: Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population.Pharmacogenetics10(1) , 67–78 (2000).
  • Hisamuddin IM , WehbiMA, ChaoA et al.: Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.Clin. Cancer Res.10(24) , 8357–8362 (2004).
  • Hisamuddin IM , WehbiMA, SchmotzerB et al.: Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.Cancer Epidemiol. Biomarkers Prev.14(10) , 2366–2369 (2005).
  • Zschocke J , KohlmuellerD, QuakE, MeissnerT, HoffmannGF, MayatepekE: Mild trimethylaminuria caused by common variants in FMO3 gene.Lancet354(9181) , 834–835 (1999).
  • Shimizu M , CashmanJR, YamazakiH: Transient trimethylaminuria related to menstruation.BMC Med. Genet.8 , 2 (2007).
  • Borbas T , ZhangJ, CernyMA, LikoI, CashmanJR: Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3.Drug Metab. Dispos.34(12) , 1995–2002 (2006).
  • Furnes B , FengJ, SommerSS, SchlenkD: Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.Drug Metab. Dispos.31(2) , 187–193 (2003).
  • Matimba A , OlukaMN, EbeshiBU et al.: Establishment of a biobank and pharmacogenetics database of African populations.Eur. J. Hum. Genet.16(7) , 780–783 (2008).
  • Sachse C , RuschenS, DettlingM et al.: Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.Clin. Pharmacol. Ther.66(4) , 431–438 (1999).
  • Dolan C , ShieldsDC, StantonA et al.: Polymorphisms of the flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in Caucasians.BMC Med. Genet.6 , 41 (2005).
  • Koukouritaki SB , PochMT, HendersonMC et al.: Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.J. Pharmacol. Exp. Ther.320(1) , 266–273 (2007).
  • Shriver MD , KittlesRA: Genetic ancestry and the search for personalized genetic histories.Nat. Rev. Genet.5(8) , 611–618 (2004).
  • Allerston CK , ShimizuM, FujiedaM, ShephardEA, YamazakiH, PhillipsIR: Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3).Pharmacogenet. Genomics.17(10) , 827–839 (2007).
  • Shimizu M , MurayamaN, NagashimaS, FujiedaM, YamazakiH: Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5´-upstream distal region and common element in proximal region.Drug Metab. Pharmacokinet.23(1) , 54–58 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.